Rallybio Corporation (RLYB)

Rallybio Statistics

Total Valuation

Rallybio has a market cap or net worth of $26.46 million. The enterprise value is -$33.05 million.

Market Cap	26.46M
Enterprise Value	-33.05M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Rallybio has 42.24 million shares outstanding. The number of shares has increased by 5.40% in one year.

Current Share Class	42.24M
Shares Outstanding	42.24M
Shares Change (YoY)	+5.40%
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	4.10%
Owned by Institutions (%)	19.17%
Float	20.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	41.05
Forward PS	n/a
PB Ratio	0.41
P/TBV Ratio	0.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.74, with a Debt / Equity ratio of 0.00.

Current Ratio	14.74
Quick Ratio	13.13
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -21.17% and return on invested capital (ROIC) is -30.96%.

Return on Equity (ROE)	-21.17%
Return on Assets (ROA)	-28.35%
Return on Invested Capital (ROIC)	-30.96%
Return on Capital Employed (ROCE)	-52.67%
Revenue Per Employee	$26,960
Profits Per Employee	-$566,800
Employee Count	25
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.87% in the last 52 weeks. The beta is -1.05, so Rallybio's price volatility has been lower than the market average.

Beta (5Y)	-1.05
52-Week Price Change	-37.87%
50-Day Moving Average	0.59
200-Day Moving Average	0.52
Relative Strength Index (RSI)	48.78
Average Volume (20 Days)	265,799

Short Selling Information

The latest short interest is 229,838, so 0.54% of the outstanding shares have been sold short.

Short Interest	229,838
Short Previous Month	284,270
Short % of Shares Out	0.54%
Short % of Float	1.13%
Short Ratio (days to cover)	0.70

Income Statement

In the last 12 months, Rallybio had revenue of $674,000 and -$14.17 million in losses. Loss per share was -$0.32.

Revenue	674,000
Gross Profit	-38.36M
Operating Income	-33.26M
Pretax Income	-14.17M
Net Income	-14.17M
EBITDA	-33.14M
EBIT	-33.26M
Loss Per Share	-$0.32

Balance Sheet

The company has $59.32 million in cash and $198,000 in debt, giving a net cash position of $59.12 million or $1.40 per share.

Cash & Cash Equivalents	59.32M
Total Debt	198,000
Net Cash	59.12M
Net Cash Per Share	$1.40
Equity (Book Value)	63.03M
Book Value Per Share	1.50
Working Capital	62.11M

Cash Flow

Operating Cash Flow	-35.00M
Capital Expenditures	n/a
Free Cash Flow	-35.00M
FCF Per Share	-$0.83

Margins

Gross Margin	n/a
Operating Margin	-4,934.72%
Pretax Margin	-2,102.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rallybio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.40%
Shareholder Yield	-5.40%
Earnings Yield	-54.36%
FCF Yield	-134.25%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	169.72%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rallybio has an Altman Z-Score of -3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3
Piotroski F-Score	2